Vote — approved

Steve Gallardo	abstain
Bill Gates	abstain
Clint Hickman	abstain
and Steve Gallardo	yes
and Clint Hickman	yes
Denny Barney	abstain
Steve Chucri	yes

39.AGREEMENT FOR OUTPATIENT SAMPLE PROGRAM WITH JANSSEN PHARMACEUTICALS, INC Adopt a Resolution which authorizes an Agreement between Janssen Pharmaceuticals, Inc. and Maricopa County through the Department of Correctional Health Services, for the purpose of a free medication program for psychiatric patients. Approve and authorize, by Resolution, Maricopa County by and through its Department of Correctional Health Services (MCDCHS), to process an non-financial Outpatient Sample Program (OSP) for

Item Text

39. AGREEMENT FOR OUTPATIENT SAMPLE PROGRAM WITH JANSSEN PHARMACEUTICALS, INC Adopt a Resolution which authorizes an Agreement between Janssen Pharmaceuticals, Inc. and Maricopa County through the Department of Correctional Health Services, for the purpose of a free medication program for psychiatric patients. Approve and authorize, by Resolution, Maricopa County by and through its Department of Correctional Health Services (MCDCHS), to process an non-financial Outpatient Sample Program (OSP) form (1050041-SUS170114941) with Janssen Pharmaceuticals, Inc., for free samples of INVEGA SUSTENNA (paliperidone palmitate), up to six (6) units per dosage, 156 mg and 234 mg. This Agreement is non-financial and is effective from June 27, 2018 until June 27, 2023. Long acting injectable (LAI) antipsychotic medications are used frequently in the community for psychiatric conditions, including schizophrenia, schizoaffective disorder, and bipolar disorder. Given the large number of jail inmates with psychiatric conditions who get treated with LAI medications in the community, best practices dictate that these medications be continued in jail for patients who are stable and compliant on LAIs. The cost of LAIs is significant. On average, 200 patients per month are receiving injectable antipsychotic medications in Maricopa County Jails. This comprises 20% of the monthly pharmacy budget for a jail population of 7500. Fortunately, pharmaceutical companies understand the burden that LAIs have on county budgets and have programs designed specifically to provide medications, free of charge, to incarcerated populations. Creating a partnership with these companies will allow for continuity of care on patients, while in jail, who are stable and compliant in the community with LAI medications. (C-26-18-008-3-00)

Attachments (2)